NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

New thought…

It seems to me that a lot of people that are either not so confident or assume doom and gloom believe that NWBO hasn’t even submitted an application or moved forward with a rolling application in the US. While a company can choose not to disclose positive developments, I am pretty sure a refuse to file would be both required to report by SEC rules which creates problems with several other laws and probably made public by FDA. Also current investigators including AK would be required to be informed of a change in any data that shifts perceptions of safety or efficacy and IRBs would require new approvals and all patients be reconsented.

A submission of data that changes this perception would also require these steps be taken. Waiting for some change in rules, as Biosect has suggested would likely mean a submission occurred. FDA is quite busy and backed up by COVID to do back and forth without purpose and intent. NWBO taking advertisement risks along the way of any of these scenarios creates all sorts of new risk. Why would anyone do that and continue to pay Advent to move forward?